# SL34 Coffee (Coffea arabica)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/sl34-coffee
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-24
**Evidence Score:** 2 / 10
**Category:** Coffee Cultivars
**Also Known As:** Coffea arabica var. SL34, SL-34, Scott Labs 34, Kenyan SL34, Loresho Estate Coffee, Arabic Coffee SL34

## Overview

SL34 Coffee (Coffea arabica) is a Kenyan heirloom cultivar prized for high cup quality and elevated caffeine content (approximately 1–1.5% dry weight), which exerts stimulant effects primarily through competitive antagonism of adenosine A1 and A2A receptors in the central nervous system. Its phytochemical profile also includes chlorogenic acids (5–12% dry weight in green beans) that may modulate [glucose metabolism](/ingredients/condition/weight-management) and [antioxidant activity](/ingredients/condition/antioxidant).

## Health Benefits

• No clinical evidence exists for SL34-specific health benefits; general C. arabica research suggests potential [cardiovascular](/ingredients/condition/heart-health) benefits (PMID 28628476 meta-analysis referenced but not specific to SL34)
• Contains caffeine (1-1.5% dry weight) which may support alertness through adenosine antagonism (mechanism inferred from general coffee research, not SL34-specific)
• Contains chlorogenic acids (5-10%) with potential [antioxidant](/ingredients/condition/antioxidant) properties (general C. arabica data, no SL34-specific studies)
• No documented immune, metabolic, or [cognitive](/ingredients/condition/cognitive) benefits specific to SL34 cultivar (evidence quality: none)
• No clinical trials have distinguished SL34 from other arabica cultivars for any health outcome (evidence quality: absent)

## Mechanism of Action

Caffeine in SL34 Coffee competitively blocks adenosine A1 and A2A receptors, reducing inhibitory neurotransmission and elevating [dopamine](/ingredients/condition/mood) and norepinephrine signaling, which promotes wakefulness and [cognitive](/ingredients/condition/cognitive) alertness. Chlorogenic acids, particularly 5-caffeoylquinic acid, inhibit glucose-6-phosphatase activity in the liver and activate Nrf2-mediated [antioxidant](/ingredients/condition/antioxidant) pathways, potentially attenuating postprandial glucose spikes. Diterpenes such as cafestol and kahweol, present in unfiltered preparations, modulate bile acid [metabolism](/ingredients/condition/weight-management) and may influence [LDL cholesterol](/ingredients/condition/heart-health) levels via effects on hepatic LDL receptor expression.

## Clinical Summary

No randomized controlled trials have been conducted specifically on the SL34 cultivar; available evidence derives from general Coffea arabica research that cannot be extrapolated directly to this cultivar's unique phytochemical ratios. A 2017 meta-analysis (PMID 28628476) of 21 prospective cohort studies (n > 1,000,000) found habitual coffee consumption associated with a 15–20% relative risk reduction in cardiovascular mortality, though cultivar-specific contributions were not assessed. Chlorogenic acid supplementation trials using standardized green coffee extract (400–800 mg/day) have reported modest reductions in systolic [blood pressure](/ingredients/condition/heart-health) (−4.7 mmHg in one 12-week RCT, n=117) and fasting glucose, but these findings are not attributable to SL34 specifically. Overall, the evidence supporting SL34-specific health claims is absent; general arabica data provides a plausible mechanistic framework only.

## Nutritional Profile

SL34 Coffee (Coffea arabica) green bean composition per 100g dry weight: Carbohydrates 60-65g (primarily sucrose 6-9g, polysaccharides 35-40g including arabinogalactans and mannans); Protein 10-13g (rich in glutamic acid, aspartic acid; bioavailability limited due to Maillard reactions during roasting); Lipids 12-18g (60% linoleic acid, 30% palmitic acid, 8% oleic acid; wax layer contains diterpenes cafestol and kahweol at approximately 10-12mg/g oil); Caffeine 1.0-1.5% dry weight (10-15mg/g); Chlorogenic acids (CGAs) 5-8% dry weight total, primarily 5-caffeoylquinic acid (5-CQA) at 3-5g/100g, with dicaffeoylquinic acids and feruloylquinic acids comprising remainder — CGA content notably higher in SL34 grown at elevation above 1700m; Trigonelline 0.5-1.0g/100g (partially converts to niacin during roasting, yielding approximately 10-40mg niacin per 100g roasted bean); Minerals: potassium 1600-1700mg/100g (highest bioavailable mineral in brewed coffee), magnesium 150-200mg/100g, phosphorus 140-160mg/100g, manganese 1.0-2.0mg/100g, trace copper 0.3-0.5mg/100g; B vitamins: niacin (B3) increases with roasting to 10-40mg/100g roasted bean, riboflavin (B2) approximately 0.2mg/100g; Melanoidins (formed during roasting) 25-30% of roasted bean mass — act as dietary fiber analogs with [prebiotic](/ingredients/condition/gut-health) and [antioxidant](/ingredients/condition/antioxidant) properties, bioavailability partially characterized; Roasting reduces CGAs by 50-70% depending on roast level while increasing melanoidin content; Brewed cup (240ml) delivers approximately 80-120mg caffeine, 70-200mg CGAs, and 300-400mg potassium based on standard extraction; SL34-specific compositional data is limited and values are interpolated from C. arabica Kenyan variety studies.

## Dosage & Preparation

No clinically studied dosage ranges exist for SL34 in extract, powder, or standardized forms. It is consumed as brewed coffee (typical 1-2 cups/day, approximately 100-200mg caffeine), with no standardization noted in available sources. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Caffeine from SL34 Coffee can cause [insomnia](/ingredients/condition/sleep), tachycardia, anxiety, and gastrointestinal distress at intakes exceeding 400 mg/day in healthy adults; individuals with cardiac arrhythmias or hypertension should use caution. Caffeine inhibits CYP1A2 metabolism and may potentiate the effects of stimulant medications, reduce efficacy of adenosine-based antiarrhythmics, and interact with warfarin by altering clotting factor synthesis. Chlorogenic acids may enhance the hypoglycemic effect of metformin and insulin, warranting [blood glucose](/ingredients/condition/weight-management) monitoring in diabetic patients. Pregnant individuals are advised to limit caffeine intake to under 200 mg/day (per WHO guidelines), and unfiltered SL34 preparations containing cafestol may exacerbate dyslipidemia in susceptible populations.

## Scientific Research

No clinical trials, RCTs, or meta-analyses specific to SL34 coffee were identified in PubMed-indexed studies. While general C. arabica research exists on caffeine and polyphenols (e.g., PMID 28628476 for meta-analysis on coffee and [cardiovascular risk](/ingredients/condition/heart-health)), no evidence distinguishes SL34 from other cultivars due to its use as a beverage rather than a standardized biomedical ingredient.

## Historical & Cultural Context

SL34 has no documented role in traditional medicine systems, as it was selectively bred in the 1930s for agricultural yield and flavor, not medicinal purposes. While Coffea arabica has historical use in Ethiopian/Yemeni traditions for stimulation since the 15th century, SL34 postdates this by centuries and remains a modern Kenyan export cultivar developed for commercial coffee production.

## Synergistic Combinations

L-theanine, Green tea extract, Rhodiola rosea, B-complex vitamins, Magnesium

## Frequently Asked Questions

### What makes SL34 Coffee different from other Coffea arabica varieties?

SL34 is a Kenyan selection derived from the Tanganyika Drought Resistant (TDR) variety, developed by Scott Agricultural Laboratories in the 1930s, and is valued for superior cup quality, blackcurrant flavor notes, and adaptability to high-altitude, high-rainfall growing conditions. Its chlorogenic acid and caffeine concentrations may differ from mass-market arabica cultivars due to distinct genetic expression, though no published comparative phytochemical analyses between SL34 and commercial arabica blends currently exist.

### How much caffeine does SL34 Coffee contain per cup?

SL34, like most Coffea arabica cultivars, contains approximately 1–1.5% caffeine by dry bean weight; a standard 8 oz (237 mL) brewed cup typically delivers 80–120 mg of caffeine, depending on roast level, grind size, and brew method. Lighter roasts retain slightly more caffeine by mass than dark roasts because the roasting process causes minor caffeine volatilization, though the difference per cup volume is marginal.

### Does SL34 Coffee have more antioxidants than regular coffee?

SL34 green beans contain chlorogenic acids (primarily 5-caffeoylquinic acid) at roughly 5–12% dry weight, comparable to other high-quality arabica cultivars, but no peer-reviewed study has directly compared SL34's total antioxidant capacity (measured by ORAC or DPPH assays) to commercial arabica blends. Roasting significantly reduces chlorogenic acid content by 50–95% depending on roast degree, meaning lighter SL34 roasts will deliver substantially more chlorogenic acids per cup than dark roasts of the same cultivar.

### Can SL34 Coffee help with weight loss?

There is no SL34-specific clinical evidence for weight loss; however, caffeine increases resting metabolic rate by approximately 3–11% and enhances lipolysis through inhibition of phosphodiesterase, raising intracellular cAMP and activating hormone-sensitive lipase in adipose tissue. Green coffee extract standardized for chlorogenic acids (not specific to SL34) showed modest weight reduction (−1.7 to −2.5 kg vs. placebo) in a Cochrane-reviewed meta-analysis of five small RCTs, though study quality was rated low.

### Is SL34 Coffee safe to drink every day?

For healthy, non-pregnant adults, moderate daily consumption of 3–4 cups of brewed SL34 Coffee (delivering approximately 300–400 mg caffeine) is generally regarded as safe per EFSA and FDA assessments, with observational data even suggesting long-term cardiovascular and neuroprotective associations. Individuals with anxiety disorders, GERD, hypertension, arrhythmias, or those taking CYP1A2-sensitive medications such as clozapine or theophylline should consult a healthcare provider, as daily caffeine intake can exacerbate these conditions or alter drug plasma levels.

### Is SL34 Coffee safe to consume during pregnancy or while breastfeeding?

SL34 Coffee contains 1-1.5% caffeine by dry weight, and caffeine consumption during pregnancy is generally recommended to be limited to 200 mg per day or less according to major health organizations. Pregnant and breastfeeding individuals should consult their healthcare provider before consuming SL34 Coffee, as caffeine crosses the placenta and passes into breast milk. A typical cup of SL34 Coffee may contain 95-200 mg of caffeine depending on brewing method and cup size.

### Does SL34 Coffee interact with common medications like blood thinners or stimulants?

SL34 Coffee's caffeine content may potentiate the effects of stimulant medications and could theoretically interact with anticoagulants like warfarin, though the clinical significance is typically low with moderate consumption. Individuals taking medications for anxiety, sleep disorders, or heart conditions should discuss caffeine intake with their healthcare provider, as caffeine can exacerbate certain conditions. If you are on prescription medications, consult your doctor before making SL34 Coffee a regular part of your routine.

### What is the strongest evidence available for health benefits specific to SL34 Coffee cultivar?

Currently, there is no clinical evidence demonstrating health benefits specific to the SL34 cultivar itself; most research on coffee's cardiovascular and antioxidant benefits applies broadly to Coffea arabica species rather than individual varieties. While SL34 contains chlorogenic acids and other compounds found in arabica coffee that have been studied for potential health effects, these benefits are not established exclusively for SL34. If you are considering SL34 Coffee for therapeutic purposes, be aware that marketing claims about SL34-specific benefits lack dedicated clinical research support.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*